Beneficial Effects of Bioactive Peptides Derived from Soybean on Human Health and Their Production by Genetic Engineering 313

Hypocholesterolemic activity
The US Food and Drug Administration has approved health claims concerning the role of soy protein in reducing the risk of coronary heart disease; only people with soy allergy (about 0.5% of the global population) should avoid eating foods containing soy protein.
However, a recent randomized, double-blind, parallel-intervention trial showed no significant effect of soy supplementation (30 g soy protein, 9 g cotyledon fiber, 100 mg isoflavones) on blood lipid levels compared with a placebo (30 g casein) in hypercholesterolemic subjects after 24 weeks (Hermansen et al., 2005) . Therefore, the biological efficacy of a soy protein-rich diet remains controversial. In addition, the final mechanism responsible for plasma cholesterol reduction remains to be elucidated, although nutrigenomic analysis has revealed significant differences in hepatic gene expression concerning lipid and energy metabolism, transcription factor regulation, and antioxidant enzyme production in animals fed soy protein compared with those fed casein (Nagasawa et al., 2002; Takamatsu et al., 2004) . Several studies in cells and validated animal models have suggested that the mechanism of action of soy protein is related to the direct activation of low-density lipoprotein receptors or gene expression in liver cells (Khosla et al., 1989; Lovati et al., 2000; Manzoni et al., 2003) , or modulation of both synthesis and catabolism of low-density lipoproteins by specific proportions of dietary amino acids corresponding to soy protein (Lovati et al., 1987; Sirtori et al., 1993; Tovar et al., 2002; Vahouny et al., 1996) . Lovati et al. (1996 Lovati et al. ( , 2000 demonstrated that the smaller major peptide (i.e., 7S globulin) from soy protein, devoid of isoflavone components, inhibits apolipoprotein B secretion and sterol biosynthesis in HepG2 cells. Dietary soy protein hydrolysates not only inhibit the absorption of dietary lipids and increase the absorption of dietary carbohydrates but also augment postprandial energy expenditure, accompanied by a postprandial increase in the oxidation of dietary carbohydrates, in type II diabetic mice (Ishihara et al., 2003) .
Anti-obesity activity
Recently, the incidence of obesity has dramatically increased. Obesity is considered a serious problem associated with the development of major human metabolic diseases. This phenomenon occurs as a result of an imbalance between energy intake and energy expenditure that leads to adipocyte accumulation (Aoyama et al., 2000a; Aoyama et al., 2000b) . Therefore, low-energy diets such as a high-protein diet, which helps maintain body protein during restricted energy intake, are used for treating obese patients with diabetes (Hwang et al., 2005) . Obesity is caused by increased adipocyte hyperplasia and hypertrophy as well as fat storage, which induces the transformation of pre-adipocytes into adipocytes (Caro et al., 1989) . Nagasawa et al. (2003) reported that soy protein isolates can lower the triglyceride content and fatty acid synthase mRNA level in adipose tissue. Therefore, they suggested that soy protein isolates control the gene expressions in adipose tissue and effectively regulate adipogenesis. Further, the anti-obesity benefits of the black soybean peptide, such as reduction in body weight and adipose tissue weight, have been observed. Kim et al. (2007) synthesized a tripeptide from soy protein and investigated its activity. In Western blot analysis, the synthetic peptide exhibited a similar inhibitory effect to 5-aminoimidazole-4-carboxamide riboside (AICAR), which inhibits the expressions of adipogenic markers and transcription factors for adipogenesis (Haro et al., 1996; Kim et al., 2007) .
Anti-inflammatory activity
Peptide-induced anti-inflammatory activities include modulation of inflammation, binding of toxins, and neutralization of bacteria and fungi. Inflammation associated with skin conditions is often a result of bacterial involvement, partially because of lipopolysaccharide released from the outer membrane of Gram-negative bacteria and lipotechoic acid released from Gram-positive bacteria. Innate-immunity peptides such as defensins and LL-37 are known to bind and neutralize bacterial debris including lipopolysaccharide and lipotechoic acid, resulting in the downregulation of pro-inflammatory cytokines (Mookherjee et al., 2006) . Another example is the suppression of propionibacterium acne-stimulated cytokine release by granulysin-derived peptides (McInturff et al., 2005) . Oligopeptide-10 (Granactive Oligopeptide-10; Grant Industries, Elmwood Park, NJ, USA), a synthetic peptide that binds to lipotechoic acid, has been developed for topical anti-acne treatment. It has also shown potential in mitigating symptoms associated with yeast and fungal colonization, such as in dandruff, seborrheic dermatitis, and tinea pedis (Howell, 2007) . The combination of oligopeptide-10 with a peptide capable of downregulating cytokine-mediated responses involving interleukin-6 and interleukin-8 may have multiple applications, particularly for sensitive skin. Such a product would combine the benefits of binding pro-inflammatory toxins and reducing redness. Recent findings also suggest that a lack of modulation of peptides of the innate system may contribute to various skin conditions (Schauber & Gallo, 2009) . Notably, mounting evidence has shown that overexpression of a pro-inflammatory component of LL-37 is an important contributor to the development of rosacea (Yamasaki et al., 2007) .
Anticancer activity
Soy protein may also have anticancer effects. Azuma et al. (2000) and Kanamoto et al. (2001) demonstrated that feeding of an insoluble, high-molecular-weight protein fraction prepared from a proteinase-treated soybean protein isolate suppressed colon and liver tumorigenesis induced by azoxymethane and dietary deoxycholate in experimental animals. Bile acid plays a critical role in liver and colon tumorigenesis. The authors hypothesized that the high-molecular-weight protein fraction exerted these protective effects against colon and liver tumorigenesis by interfering with the enterohepatic circulation of bile acids, thus inhibiting their resorption in the intestine and increasing their fecal excretion. Peptides found in the feces of animals fed with the high-molecular-weight protein fraction were rich in hydrophobic amino acids; therefore, the authors suggested that this protein fraction forms nondissociable complexes with bile acids in the intestine through hydrophobic binding, which are then excreted via feces. High-molecular-weight protein fractions may therefore be used in functional foods to prevent the tumor-promoting activity of bile acids in the liver and colon.
Antioxidant activity
A high level of reactive oxygen species causes DNA, protein, lipid, and carbohydrate damage in the host (Murosaki et al., 2000) . Hydrolysates of soy proteins contain antioxidant peptides (Chen et al., 1998) . These peptides show high activity against the peroxidation of linoleic acid, paraquat-induced oxidative stress in rats, and scavenging effects on peroxynitrite, active oxygen, and free radical species (Takenaka et al., 2003) . They may therefore help prevent some free radical-related diseases. 
Hypotensive activity
The angiotensin-converting enzyme (dipeptidyl carboxypeptidase, EC 3.4.15.1) plays an important role in regulating blood pressure. It increases blood pressure by converting inactive angiotensin I to potent vasoconstrictor angiotensin II and inactivating the vasodilator bradykinin (Yang et al., 1970) . Therefore, inhibition of the angiotensinconverting enzyme reduces the activity of angiotensin II and increases the bradykinin level, thus lowering blood pressure. Soybean is a valuable source of inhibitors of the angiotensin-converting enzyme (Ahn et al., 2000; Shin et al., 2001 ). Inhibitors of this enzyme are now widely used as antihypertensive agents, causing a fall in blood pressure comparable to that produced by thiazides, and calcium antagonists (Pool et al., 1989) . Many peptides isolated by the hydrolysis of food proteins have inhibitory activity against the enzyme and reduce blood pressure after oral administration (Ahn et al., 2000; Je et al., 2004; Yamamoto, 1997) . Daily use of food with such peptides may be effective in maintaining blood pressure at the normal level.
Anti-fatigue activity
Exercise-induced fatigue is a listlessness resulting from excessive exertion or "overexercise," leading to diminished bodily and mental functions. It is attributable to the following factors. First, free radicals cause metabolic disturbances; both normal and exhaustive exercises can cause an increase in free radicals in hepatic tissues, resulting in hepatocyte damage (Gul et al., 2006; Voces et al., 1999) . Second, exercise causes the production and accumulation of products of metabolism, such as lactic acid. Third, exercise promotes the mobilization and consumption of energy sources such as glycogen (Ikeuchi et al., 2006) . In addition, overexercise diminishes the brain's supply of oxygen, which leads to fatigue. Soybean peptides purified by ultrafiltration and gel chromatography have been shown to extend the swimming time of mice, effectively delay increases in their blood lactate level, and enhance the storage of hepatic glycogen. Soybean peptides are rich in amino acids such as leucine (23.6%), valine (12.22%), lysine (10.01%), isoleucine (8.8%), and phenlyalanine (8.75%). In addition, soybean peptides contain 4.74% aspartate and 5.55% glutamate, which help in performing exercise (Guezennec et al., 1998) and delaying fatigue (Marquezi et al., 2003) . A supply of amino acids, especially branched-chain amino acids, can improve exercise ability and markedly retard the catabolism of proteins in muscle during exercise (Blomstrand & Newsholme, 1992) . Bazzarva et al. (1992) indicated that the amount of amino acids, especially alanine, glycine, valine, gamma-aminobutyric acid, isoleucine, threonine, serine, and tyrosine, in the plasma decreases rapidly during endurance testing. Red mold rice contains alanine, valine, and serine, implying that consumption of this rice can enhance exercise ability via its constituent amino acids. In addition, red mold rice contains gamma-aminobutyric acid and glutamic acid, which have positive effects on the nervous system and could help in executing exercise (Guezennec et al., 1998) . Marquezi et al. (2003) indicated that aspartic acid is helpful in oxidative deamination and can lower the blood ammonia concentration, thus delaying fatigue.
Anti-aging activity
Many protein hydrolysates have been used in cosmetic formulations for decades because of their ability to stimulate skin firmness, tone, and elasticity as well as counteract skin aging. Until now, these peptides were poorly studied and their efficacy was poorly demonstrated.
During aging, the epidermis and dermis become thin; therefore, an efficient anti-aging product should be able to stimulate the metabolism of senescent fibroblasts and keratinocytes in order to increase the quantity of extracellular matrix components such as collagen and glycosaminoglycans. A parallel study performed on an in vitro skin-equivalent model and with human volunteers demonstrated the efficacy of a specific soy biopeptide against aging. This biopeptide induced a significant increase in glycosaminoglycan synthesis both in vitro and in vivo after a one-month treatment. This new cosmetic ingredient was also able to stimulate collagen synthesis in vitro and in vivo (Andre-Frei et al., 1999) . Enzyme-inhibitory peptides directly or indirectly inhibit the activity of enzymes. Protein or peptides naturally extracted from soybean seeds can inhibit the formation of proteinases (Centerchem, Inc., Norwalk, CT, USA). Soy protein is frequently used as an anti-aging, skinmoisturizing, anti-solar, cleansing, and hair-promoting agent. In a randomized, doubleblind, placebo-controlled study (Sudel et al., 2005) , soy extract and placebo creams were applied to the volar part of the forearm of 21 healthy women; the papillary index increased to a significantly greater extent with the soy extract cream than with the placebo cream (4.56 vs. 3.76 arbitrary units, P < 0.05). Another study with a pseudorandomized design in 10 Caucasian women indicated the superiority of 2% soy biopeptide emulsion to a placebo in terms of collagen synthesis and stimulation of glycosaminoglycan contents (Andre-Frei et al., 1999) .
Bioactive peptides produced by gene expression systems
In the recent years, various small peptides isolated from proteolytic hydrolysates of food proteins have shown a variety of physiological activities (Fiat et al., 1993) , such as modulating the autonomic nerve system, activating the cell immune mechanism, and improving cardiovascular system function. These discoveries are valuable for exploiting functional foods and developing new medicaments. The expression of heterologous proteins in microorganisms by genetic recombination is still the high point in the development and exploitation of modern biotechnology. An optimal expression system can be selected only if the productivity, bioactivity, purpose, and physicochemical characteristics of the protein of interest are taken into consideration, together with the cost, convenience, and safety of the system itself. E. coli has a typical prokaryotic expression system. Itakura et al. (1977) successfully expressed somatostatin, a mammalian peptide hormone, in E. coli, realizing the in vitro expression of a foreign gene in prokaryotic cells. The cost of the bioactive substance produced in medium was similar to that of the protein extracted from the brains of 500,000 sheep. The event is therefore regarded as a milestone in genetic engineering. To date, reformed E. coli has been used extensively as a cellular host for foreign protein expression because of its rapid growth, capacity for continuous fermentation, and relatively low cost. Many commercial expression systems designed for various applications and compatibilities are available. The T7-based pET expression system (Novagen, Merck KGaA, Darmstadt, Germany) is the most commonly used in recombinant protein preparation. In general, three forms of foreign proteins can be expressed in E. coli: fusion proteins, secreted proteins, and inclusion bodies. E. coli cannot perform the post-translational modifications (e.g., N-and O-linked glycosylation, fatty acid acylation, phosphorylation, and disulfide-bond formation) often required for proper folding of the secondary, tertiary, and quaternary structures as well as for the functional characteristics of the protein of interest. Obviously, these modifications www.intechopen.com
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can affect the bioactivity, function, structure, solubility, stability, half-life, protease resistance, and compartmentalization of the protein (Jung & Williams, 1997) . Figure 2 shows strategies to obtain bioactive peptides from soybean. To the best of our knowledge, the use of genetic engineering instead of other synthetic methods to obtain a protein or peptide is both time-saving and cost-effective. We have successfully used a commercial E. coli expression system to express recombinant lunasin (Liu & Pan, 2010) . In the following section, we present a representative method to obtain recombinant lunasin by using an E. coli expression system. 
Recombinant lunasin
Bioactive lunasin in current research
Lunasin is a 43-amino acid peptide with nine aspartate residues (D) at the C-terminus, an Arg-Gly-Asp (RGD) cell adhesion motif, and a conserved region of chromatin-binding proteins (Odani et al., 1987a (Odani et al., , 1987b . Previous studies showed that lunasin suppresses carcinogenesis triggered by chemical carcinogens and oncogenes both in vitro and in a mouse skin cancer model ). Hsieh et al. (2010) recently evaluated the anticancer properties of lunasin in breast cancer by using a xenograft mouse model. The US Food and Drug Administration recommends the consumption of 25 g of soy protein per day to lower cholesterol levels and reduce the risk of heart disease (Xiao, 2008) ; this supplies approximately 250 mg of lunasin. Whether this dose is sufficient for chemoprevention still needs to be determined.
In a human feeding trial for detecting the presence of lunasin in plasma after soy protein consumption, lunasin was found in the circulation, a key requirement for its bioactivity in the target organs (Dia et al., 2009) . Recently, some studies showed that lunasin can reduce low-density lipoprotein and total cholesterol levels by directly inhibiting gene expression of 3-hydroxy-3-methyl-glutaryl-CoA reductase, which reduces cholesterol biosynthesis, and increasing low-density lipoprotein receptor expression, which enhances clearance of plasma low-density lipoprotein cholesterol (Galvez, 2001) . In 2001, Galvez applied the Pichia yeast expression system for large-scale production of lunasin. Besides, lunasin and lunasin-like peptides isolated from defatted soybean flour can inhibit inflammation in lipopolysaccharide-induced RAW 264.7 cells by suppressing the nuclear factor kappa B pathway (de Mejia & Dia, 2009 ). In addition, synthetic lunasin has antioxidant properties such as linoleic acid oxidation-inhibitory and 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS) radical-scavenging activities (Hernández-Ledesma et al., 2009) . Recently, lunasin from soybean was found to promote apoptosis of HT-29 colon cells by activating mitochondrial pathways and inducing nuclear clustering (Dia & de Mejia, 2010) . Figure 3 shows the experimental design for obtaining recombinant lunasin. Fig. 3 . Flow chart of a method for obtaining recombinant lunasin via E. coli (Liu & Pan, 2010) .
Experimental design involving genetic synthesis
In the experiment, the lunasin sequence from soybean was codon-optimized for high expression in E. coli by changing the original sequence of lunasin (Odani et al., 1987b) to highly frequent codons used in the host. As shown in Figure 4 , synthesis of the lunasin gene was achieved by an overlapping extension polymerase chain reaction strategy using four oligonucleotides. Fig. 4 . Schematic of the overlapping extension polymerase chain reaction. Primer 2 and 3 were used as template primers; primer 1 and 4 were used as forward and reverse primers.
Purification and production
Lunasin is a polypeptide derived from the small subunit of soybean cotyledon-specific 2S albumin. The current research is based on extraction by plant or chemical synthesis of this polypeptide (Galvez & de Lumen, 1999) . The purification of lunasin from plant sources is tedious. To date, lunasin has been isolated from various plants such as soybean (Odani et al., 1987b) , barley (Jeong et al., 2002) , herbs (Solanum nigrum L.; Jeong et al., 2007a) , wheat (Jeong et al., 2007b) , and amaranth (Amaranthus hypochondriacus; Silva-Sanchez et al., 2008) . Natural lunasin has been extracted and purified by ion exchange chromatography and immuno-affinity column chromatography. Commercial soy products contain reasonable amounts of lunasin, ranging from 5.48 mg of lunasin per gram of protein (defatted soy flour) to 16.52 mg of lunasin per gram of protein (soy concentrate) (Jeong et al., 2003) . The lunasin content of extracts from different varieties of barley ranges from 5.93 to 8.71 mg of lunasin per gram of protein (Jeong et al., 2002) and 36.4 mg of lunasin per gram of protein in Solanum nigrum L extract (Jeong et al., 2007a) . Wheat and amaranth extracts have 3.95-17.2 mg lunasin per gram of protein (Jeong et al., 2007b) and 11.1 μg lunasin per gram of protein (Silva-Sanchez et al., 2008) , respectively. Some heterologous eukaryotic proteins such as human insulin-like growth factor II, alphainterferon, and interleukin-2 have been expressed in E. coli (Dijkema et al., 1984) . In our experiment, recombinant lunasin containing his-tag at the C-terminus was expressed in soluble form, which could be purified by immobilized metal affinity chromatography ( Figure 5) . After 4 h, the expression level was above 4.73 mg of recombinant his-tagged lunasin per liter of Luria-Bertani broth. This method does not affect the bacterial growth and expression levels. Consequently, it is easier to use an E. coli genetic expression system to express a heterologous protein than to extract the protein from plants. 
Bioactivity
For detecting the bioactivity of the recombinant peptide from E. coli, we used M10 and Raw 264.7 cells to evaluate the levels of histone acetylation and anti-inflammation. We found that recombinant his-tagged lunasin expressed by E. coli decreases acetylation in M10 cells by approximately 26.6%. The results of a histone acetylation assay depend on the cell model and source of lunasin. Galvez et al. (2001) suggested that 2 μM of lunasin isolated from soybean can efficiently prevent histone acetylation in C3H and MCF-7 cells. Jeong et al. (2002) reported that N-butyrate-treated NIH3T3 cells show an approximately 18-fold decrease in H3 acetylation after treatment with lunasin extract from barley seeds. In MCF7 cells, H3 acetylation can be completely inhibited by lunasin (Jeong et al., 2002) . Recombinant his-tagged lunasin is a 92-amino acid peptide, almost double that of native lunasin (43-amino acid residues) obtained from plants. The extra amino acid residues at the N-and Cterminals do not appear to affect the bioactivity of the recombinant protein.
Macrophage activation is associated with a significant proportion of lipopolysaccharideinduced inflammation. During this process, active macrophages produce cytotoxic inflammatory mediators, including reactive oxygen and nitrogen intermediates, hydrolytic enzymes, lipid mediators, and inflammatory cytokines (Laskin & Pendino, 1995) . In lipopolysaccharide-induced macrophages, nitric oxide is mainly produced via inducible nitric oxide synthetase (Knowles & Moncada, 1994) , which is synthesized via the nuclear factor kappa B pathway, similar to tumor necrosis factor-alpha and other pro-inflammatory cytokines such as interleukin-1beta, interleukin-6, and interleukin-12. Dia et al. (2009) the first to indicate that lunasin isolated from defatted soybean flour has some antiinflammatory activity in RAW 264.7 cells; they found lunasin can inhibit the cyclooxygenase 2-prostaglandin E2 and inducible nitric oxide synthetase-nitric oxide pathways. De Mejia and Dia et al (2009) reported that lunasin and lunasin-like peptides purified from defatted soybean flour inhibit inflammation in lipopolysaccharide-induced RAW 264.7 macrophages by suppressing the nuclear factor kappa B pathway. Chemically synthesized lunasin also has some antioxidant and anti-inflammatory properties (Hernández-Ledesma et al., 2009 ). Recombinant lunasin produced from E. coli can inhibit the release of pro-inflammatory cytokines (tumor necrosis factor-alpha and interleukin-1beta) and nitric oxide production. (Liu & Pan, 2010) 
Conclusion
We have presented several opportunities for the industrial exploitation of soy-derived bioactive peptides to enhance health and prevent disease. In this chapter, we have introduced the physiological properties of bioactive peptides from soybean and provided an example on the expression of a recombinant peptide by genetic engineering. Choosing the right expression system requires adequate time and makes the difference between success and failure. Once the protein is expressed, a suitable purification scheme can be planned. As shown in Table 1 
